Develops and commercializes patent-protected biopharmaceutical products targeting specialty, rare, and ultra-rare diseases. Its pipeline includes treatments for conditions like epidermolysis bullosa and phenylketonuria, aiming to significantly improve patient quality of life and clinical outcomes.
Funding
$5.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients with rare and ultra-rare diseases often face a lack of effective treatments, leading to significantly reduced quality of life and limited clinical options. Existing therapies may not adequately address the underlying causes or symptoms of these conditions, leaving a substantial unmet medical need.
Solution
Relief Therapeutics is a biopharmaceutical company focused on developing and commercializing novel, patent-protected products for select specialty, rare, and ultra-rare diseases. The company's pipeline targets metabolic disorders, pulmonary diseases, and dermatology/connective tissue disorders, aiming to improve treatment paradigms and deliver enhanced efficacy, safety, and convenience. Their approach focuses on advancing therapies that can significantly improve the condition and quality of life for patients and their families, allowing them to live their best possible lives and achieve their full potential.
Target Audience
The primary target audience includes patients suffering from rare and ultra-rare diseases, their families, and healthcare providers specializing in the treatment of these conditions.
Features
- Focus on rare indications for metabolic disorders such as Phenylketonuria (PKU) and Maple Syrup Urine Disease (MSUD).
- Development of treatments for pulmonary diseases, including Acute Lung Injury, Pulmonary Sarcoidosis, and Lung Fibrosis.
- Pipeline includes therapies for dermatology/connective tissue disorders like Epidermolysis Bullosa (EB).
- Aims to deliver improvements in efficacy, safety and convenience to benefit the lives of patients and their families.